We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+13.99%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.33B
AUM Growth
+$796M
Cap. Flow
-$12M
Cap. Flow %
-0.16%
Top 10 Hldgs %
60.07%
Holding
377
New
123
Increased
61
Reduced
77
Closed
82

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$68.6M
2
ARGX icon
argenx
ARGX
+$55M
3
SNY icon
Sanofi
SNY
+$50.7M
4
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$50.5M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$42.3M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$48.6M
2
KDP icon
Keurig Dr Pepper
KDP
+$45.5M
3
INCY icon
Incyte
INCY
+$45.2M
4
UNH icon
UnitedHealth
UNH
+$37.3M
5
CPB icon
Campbell Soup
CPB
+$32M

Sector Composition

Rank Sector Weight
1 Healthcare 34.97%
2 Consumer Staples 5.35%
3 Consumer Discretionary 4.92%
4 Technology 3.86%
5 Communication Services 1.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIAFW icon
276
bioAffinity Technologies
BIAFW
$17.6K ﹤0.01%
204,082
– –
DFSCW
277
DEFSEC Technologies Warrant
DFSCW
$16.8K ﹤0.01%
120,000
– –
IVDAW icon
278
Iveda Solutions Warrant
IVDAW
$47.6K
$15.9K ﹤0.01%
145,000
– –
TNONW icon
279
Tenon Medical Inc Warrant
TNONW
$1.49K
$14.2K ﹤0.01%
1,780,000
+1,602,000
+900% +$74.8K
APVO icon
280
Aptevo Therapeutics
APVO
$5.15M
– –
-2
Closed -$283K
GROY.WS
281
DELISTED
Gold Royalty Corp. Warrants, each warrant exercisable for one common share at an exercise price of $7.50
GROY.WS
$4.75K ﹤0.01%
448,000
– –
NXLIW
282
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$2.86K ﹤0.01%
325,000
– –
BNCWW
283
CEA Industries Inc Warrant
BNCWW
$2.66K ﹤0.01%
700,000
– –
RVSNW icon
284
Rail Vision Ltd Warrant
RVSNW
$967K
$2.49K ﹤0.01%
1,089,500
– –
DBGIW
285
DELISTED
Digital Brands Group, Inc. Warrant
DBGIW
$2.2K ﹤0.01%
+722,890
New +$6.88M
NEXRW
286
Nexera Technologies Ltd Warrant
NEXRW
$1.22K ﹤0.01%
480,769
– –
AIMDW icon
287
Ainos Warrants
AIMDW
$1.05K ﹤0.01%
25,000
– –
CINGW icon
288
Cingulate Inc Warrants
CINGW
$28.9K
$615 ﹤0.01%
410,000
– –
EDBLW
289
Edible Garden AG Warrant
EDBLW
$66.2K
$571 ﹤0.01%
800,000
+773,333
+2,900% +$15.3K
AREBW
290
DELISTED
American Rebel Holdings Warrants
AREBW
$193 ﹤0.01%
4,819
+4,626
+2,397% +$4.21K
BRSHW
291
DELISTED
Bruush Oral Care Inc. Warrant
BRSHW
$163 ﹤0.01%
600,962
+576,924
+2,400% +$5.54K
DRMAW icon
292
Dermata Therapeutics Warrant
DRMAW
$14.1K
$142 ﹤0.01%
325,000
+304,687
+1,500% +$4.72K
TCBPW
293
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
$61 ﹤0.01%
1,882,352
+1,844,705
+4,900% +$43.2K
AGRIW
294
DELISTED
AgriFORCE Growing Systems Ltd Warrant
AGRIW
$42 ﹤0.01%
600,000
– –
AAL icon
295
American Airlines Group
AAL
$10.5B
– –
-12,713
Closed -$163K
AAP icon
296
Advance Auto Parts
AAP
$3.45B
– –
-3,630
Closed -$203K
ACXP icon
297
Acurx Pharmaceuticals
ACXP
$6.66M
– –
-25,000
Closed -$750K
ADTX
298
DELISTED
ADITXT INC
ADTX
– –
0
– -$350K
ADV icon
299
Advantage Solutions
ADV
$368M
– –
-84,440
Closed -$6M
AEO icon
300
American Eagle Outfitters
AEO
$2.97B
– –
-14,478
Closed -$240K
10 11
12
13 14

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Armistice Capital held 377 positions worth $7.33B, up 12% from $6.53B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Armistice Capital's Q4 2023 filing shows 123 new, 61 increased, 77 reduced and 82 closed positions. Its largest new stake was Sanofi: 1,036,000 shares worth $51.5M. The largest sale was Mirati Therapeutics, Inc. Common Stock, an estimated $48.6M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 34% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

  • Armistice Capital's largest Q4 2023 buy was Sanofi: 1,036,000 shares worth $51.5M.
  • Armistice Capital added most to GSK in Q4 2023, an estimated $68.6M increase.
  • Armistice Capital's biggest Q4 2023 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $48.6M.
  • Armistice Capital fully exited Keurig Dr Pepper in Q4 2023, selling an estimated $45.5M.
  • Armistice Capital's ten largest holdings make up 60% of its $7.33B portfolio in Q4 2023.
  • Armistice Capital opened 123 new positions and closed 82 in Q4 2023.
  • Armistice Capital's portfolio value rose 12% quarter-over-quarter to $7.33B.

Based on Armistice Capital's 13F filing for Q4 2023, filed 13 Feb 2024.